| Xiromed SA - Sitagliptin Xiromed 25 mg, Filmtabletten | | 68914 | | 01 | | Sitagliptin Xiromed 25 mg | | Filmtabletten | | A10BH01 | | Sitagliptin | | 17.10.2022 | | |
| | Composition | | sitagliptinum 25 mg ut sitagliptini hydrochloridum monohydricum, calcii hydrogenophosphas, cellulosum microcristallinum, carmellosum natricum conexum, natrii stearylis fumaras, magnesii stearas, Überzug: lactosum monohydricum 1.2 mg, hypromellosum, E 171, triacetinum, E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.675 mg. | | Packungsbestandteile | | Filmtabletten | | | | Principe actif | Concentr. |
|---|
| Sitagliptin | 25 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Calcium Hydrogenphosphat | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrat | 1.2 mg | Überzug | | Magnesii Stearas | | | | Natrii Stearylis Fumaras | | | | Pro Compresso Obducto | | | | Triacetinum | | |
|
| |
|
